The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
17 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $9,584,779 in first-year total cost, median $535,986.
Most frequent study sections
- Special Emphasis Panel[ZAI1 FDS-M (M1)]16
- ZAI1-FDS-M(M1)1
Most frequent institutions
- KANSAS STATE UNIVERSITY2
- YALE UNIVERSITY2
- CLEVELAND CLINIC LERNER COM-CWRU1
- INDIANA UNIVERSITY INDIANAPOLIS1
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Heritable immunization of the white-footed mouse reservoir of Lyme disease1R01AI152209-01 | ESVELT, KEVINJAENISCH, RUDOLFMARASCO, WAYNE A.MARKOULAKI, STYLIANITELFORD, SAM R | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $957,529 | ZAI1 |
| 2021 | Rocky Mountain Spotted Fever Vaccine Development1R01AI152417-01 | GANTA, ROMAN R. | KANSAS STATE UNIVERSITY, KS | $760,028 | ZAI1 |
| 2021 | Vaccines for Prevention of RG3 and RG4 Emerging Tickborne Viral Deseases1R01AI152241-01 | VERARDI, PAULO H | UNIVERSITY OF CONNECTICUT STORRS, CT | $526,077 | ZAI1 |
| 2021 | Molecular basis of immunity to tick-borne rickettsioses1R01AI152208-01 | KIM, HWAN KEUN | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $504,201 | ZAI1 |
| 2021 | Targeted Prevention of Human Ehrlichiosis1R01AI152223-01 | RIKIHISA, YASUKO | OHIO STATE UNIVERSITY, OH | $393,750 | ZAI1 |
| 2021 | Efficacy of novel reservoir-host targeted bait formulations against a tick-borne pathogen1R01AI152233-01 | SESHU, JANAKIRAM | UNIVERSITY OF TEXAS SAN ANTONIO, TX | $375,000 | ZAI1 |
| 2020 | Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi1R01AI152210-01 | HU, LINDEN TLEWIS, KIM | TUFTS UNIVERSITY BOSTON, MA | $743,299 | ZAI1 |
| 2020 | Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine1R01AI152207-01 | GEISBERT, THOMAS WILLIAM | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $670,889 | ZAI1 |
| 2020 | Targeting Cyclic Dinucleotide Signaling Pathways to Interrupt the Nature Cycle of Borrelia burgdorferi1R01AI152235-01 | SINTIM, HERMAN OYANG, X. FRANK | INDIANA UNIVERSITY INDIANAPOLIS, IN | $659,925 | ZAI1 |
| 2020 | Vaccines Against Ehrlichia and Anaplasma Species Infections1R01AI152418-01 | GANTA, ROMAN R. | KANSAS STATE UNIVERSITY, KS | $635,465 | ZAI1 |
| 2020 | Tickborne SFTS Virus Vaccine Development1R01AI152190-01 | JUNG, JAE U | CLEVELAND CLINIC LERNER COM-CWRU, OH | $595,000 | ZAI1 |
| 2020 | Development of a Virus-Like Particle Vaccine for Powassan Virus1R01AI152192-01 | HIRSCH, ALEC J | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $568,164 | ZAI1 |
| 2020 | Development of vaccines targeting a tick-borne phlebovirus1R01AI152236-01 | BATES, PAUL | UNIVERSITY OF PENNSYLVANIA, PA | $535,986 | ZAI1 |
| 2020 | Structure-based Vaccine Design for CCHFV1R01AI152246-01 | CHANDRAN, KARTIKMCLELLAN, JASON SCOTT | UNIVERSITY OF TEXAS AT AUSTIN, TX | $441,966 | ZAI1 |
| 2020 | Antigen Discovery and Vaccine Development for Human Babesia Parasites1R01AI152220-01 | BEN MAMOUN, CHOUKRI | YALE UNIVERSITY, CT | $418,750 | ZAI1 |
| 2020 | Ixodes scapularis saliva proteins that elicit tick immunity1R56AI152206-01 | CRAFT, JOSEPH EDGARFIKRIG, EROL | YALE UNIVERSITY, CT | $418,750 | ZAI1 |
| 2020 | Peptide-vaccine development against Lyme disease1R01AI152219-01 | BARBIER, MARIETTE | WEST VIRGINIA UNIVERSITY, WV | $380,000 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.